期刊的影响因子--文章列表

期刊文章列表
Sang Hoon Lee，Jae Geun Song，Hyo-Kyung Han（College of Pharmacy，Dongguk University-Seoul）.Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system[J].Acta Pharmaceutica Sinica B,2022,第11期 Jie Tu，Na Liu，Yahui Huang，Wanzhen Yang，Chunquan Sheng（School of Pharmacy，Second Military Medical University）.Small molecules for combating multidrug-resistant superbug Candida auris infections[J].Acta Pharmaceutica Sinica B,2022,第11期 Liping Liao^1,2，Wenzhen Dang^3,1，Tingting Lin^1,2，Jinghua Yu¹，Tonghai Liu^1,2，Wen Li¹，Senhao Xiao^1,2，Lei Feng^1,2，Jing Huang^1,2，Rong Fu¹，Jiacheng Li^1,2，Liping Liu^1,2，Mingchen Wang^1,2，Hongru Tao¹，Hualiang Jiang^1,2，Kaixian Chen^1,2，Xingxing Diao¹，Bing Zhou^1,4，Xiaoyan Shen³，Cheng Luo^3,1,2,4,5（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Department of Pharmacology & the Key Laboratory of Smart Drug Delivery，Ministry of Education，School of Pharmacy，Fudan University；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences；School of Pharmaceutical Sciences，Zhejiang Chinese Medical University）.A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6[J].Acta Pharmaceutica Sinica B,2022,第11期 Hongxi Hu，Cuicui Xie，Huiyan Xu，Liyun Zhou（Pharmcube（Beijing） Co.，Ltd.）.Drug discovery in China：A snapshot of recent progress[J].Acta Pharmaceutica Sinica B,2022,第11期 Qian Hu¹，Jiaqi Yao¹，Xiajia Wu¹，Juan Li¹，Guixiang Li¹，Wenfu Tang¹，Jingping Liu²，Meihua Wan¹（Department of Integrated Traditional Chinese and Western Medicine，National Clinical Research Center for Geriatrics，West China Hospital，Sichuan University；NHC Key Laboratory of Transplant Engineering and Immunology，Frontiers Science Center for Disease-Related Molecular Network，West China Hospital，Sichuan University）.Emodin attenuates severe acute pancreatitis-associated acute lung injury by suppressing pancreatic exosome-mediated alveolar macrophage activation[J].Acta Pharmaceutica Sinica B,2022,第10期 Ling Zou^1,2，Minru Liao²，Yongqi Zhen²，Shiou Zhu²，Xiya Chen¹，Jin Zhang^1,2，Yue Hao¹，Bo Liu²（School of Pharmaceutical Sciences，Health Science Center，Shenzhen University；State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University）.Autophagy and beyond：Unraveling the complexity of UNC-51-like kinase 1（ULK1） from biological functions to therapeutic implications[J].Acta Pharmaceutica Sinica B,2022,第10期 Xin Cao¹，Xiaojing Du¹，Heng Jiao¹，Quanlin An¹，Ruoxue Chen¹，Pengfei Fang²，Jing Wang²，Biao Yu²（Zhongshan Hospital Institute of Clinical Science，Fudan University Shanghai Medical College；State Key Laboratory of Bio-organic and Natural Products Chemistry，Center for Excellence in Molecular Synthesis，Shanghai Institute of Organic Chemistry，Chinese Academy of Sciences）.Carbohydrate-based drugs launched during 2000-2021[J].Acta Pharmaceutica Sinica B,2022,第10期 Shan Liu^1,2，Xue Wu³，Sutapa Chandra²，Christopher Lyon²，Bo Ning²，Li jiang¹，Jia Fan²，Tony Y.Hu²（Sichuan Provincial Key Laboratory for Human Disease Gene Study，Department of Medical Genetics，Department of Laboratory Medicine，Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital；Department of Biochemistry and Molecular Biology，Center for Cellular and Molecular Diagnosis，School of Medicine，Tulane University；The M.O.E.Key Laboratory of Laboratory Medical Diagnostics，the College of Laboratory Medicine，Chongqing Medical University；Sichuan Provincial Key Laboratory for Human Disease Gene Study，Department of Medical Genetics，Department of Laboratory Medicine，Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital）.Extracellular vesicles：Emerging tools as therapeutic agent carriers[J].Acta Pharmaceutica Sinica B,2022,第10期 Xiaoqing Zhou，Shaoyang Zhao，Tingting Liu，Lu Yao，Meimei Zhao，Xiaoming Ye，Xiaowen Zhang，Qiang Guo，Pengfei Tu，Kewu Zeng（State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University）.Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase[J].Acta Pharmaceutica Sinica B,2022,第10期 Xueping Lei^1,2，Zhan Li¹，Yihang Zhong¹，Songpei Li¹，Jiacong Chen¹，Yuanyu Ke¹，Sha Lv¹，Lijuan Huang¹，Qianrong Pan¹，Lixin Zhao¹，Xiangyu Yang¹，Zisheng Chen²，Qiudi Deng⁴，Xiyong Yu¹（Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology，the NMPA and State Key Laboratory of Respiratory Disease，School of Pharmaceutical Sciences and the Fifth Affiliated Hospital，Guangzhou Medical University；Department of Respiratory and Critical Care Medicine，the Sixth Affiliated Hospital of Guangzhou Medical University，Qingyuan People's Hospital；Department of Respiratory and Critical Care Medicine，the Sixth Affiliated Hospital of Guangzhou Medical University，Qingyuan People’s Hospital；GMU-GIBH Joint School of Life Sciences，Guangzhou Medical University）.Gli1 promotes epithelial-mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability[J].Acta Pharmaceutica Sinica B,2022,第10期 Leyang Wu^1,2，Lin Li¹，Shufeng Li³，Lina Liu¹，Wenjie Xin¹，Chenyang Li¹，Xingpeng Yin¹，Xuebo Xu¹，Feifei Bao¹，Zichun Hua^1,2,4（The State Key Laboratory of Pharmaceutical Biotechnology，School of Life Sciences，Nanjing University；Changzhou High-Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc.；Key Laboratory of Developmental Genes and Human Disease in Ministry of Education，Department of Biochemistry and Molecular Biology，Medical School of Southeast University；School of Biopharmacy，China Pharmaceutical University）.Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma[J].Acta Pharmaceutica Sinica B,2022,第10期 Jinlian Wei¹，Xin Chen¹，Yongyun Li，Ruoxi Li¹，Keting Bao¹，Liang Liao¹，Yuqing Xie¹，Tiannuo Yang¹，Jin Zhu¹，Fei Mao¹，Shuaishuai Ni³，Renbing Jia，Xiaofang Xu，Jian Li^1,4,5,6（State Key Laboratory of Bioreactor Engineering，Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism，Frontiers Science Center for Materiobiology and Dynamic Chemistry，Shanghai Key Laboratory of New Drug Design，School of Pharmacy，East China University of Science and Technology；Department of Ophthalmology，Ninth People’s Hospital，Shanghai Jiao Tong University School of Medicine；Cancer Institute，Longhua Hospital，Shanghai University of Traditional Chinese Medicine；Yunnan Key Laboratory of Screening and Research on Anti-pathogenic Plant Resources from West Yunnan，College of Pharmacy，Dali University；Clinical Medicine Scientific and Technical Innovation Center，Shanghai Tenth People's Hospital，Tongji University School of Medicine；Key Laboratory of Tropical Biological Resources of Ministry of Education，College of Pharmacy，Hainan University）.Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway[J].Acta Pharmaceutica Sinica B,2022,第10期 Ping Bai¹，Prasenjit Mondal²，Frederick A.Bagdasarian¹，Nisha Rani¹，Yan Liu¹，Ashley Gomm²，Darcy R.Tocci¹，Se Hoon Choi²，Hsiao-Ying Wey¹，Rudolph E.Tanzi²，Can Zhang²，Changning Wang¹（Athinoula A.Martinos Center for Biomedical Imaging，Department of Radiology，Massachusetts General Hospital，Harvard Medical School；Genetics and Aging Research Unit，McCance Center for Brain Health，MassGeneral Institute for Neurodegenerative Disease，Department of Neurology，Massachusetts General Hospital，Harvard Medical School）.Development of a potential PET probe for HDAC6 imaging in Alzheimer’s disease[J].Acta Pharmaceutica Sinica B,2022,第10期 Aneesh V.Karkhanis^1,2，Gopalakrishnan Venkatesan^1,3，Ryuichi Kambayashi⁴，Jacqueline Wen Hui Leow¹，Marcus Qingrui Han¹，Hiroko Izumi-Nakaseko⁴，Ai Goto⁴，Jeremy Kah Sheng Pang⁵，Boon Seng Soh^5,6，Pipin Kojodjojo⁷，Atsushi Sugiyama⁴，Eric Chun Yong Chan¹（Department of Pharmacy，Faculty of Science，National University of Singapore；A*STAR Skin Research Labs，Agency for Science，Technology and Research；Antimicrobial Resistance Interdisciplinary Research Group，Singapore-MIT Alliance for Research and Technology；Department of Pharmacology，Faculty of Medicine，Toho University；Institute of Molecular and Cell Biology，Agency for Science，Technology and Research；Department of Biological Sciences，Faculty of Science，National University of Singapore；Department of Medicine，Yong Loo Lin School of Medicine，National University of Singapore）.Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts[J].Acta Pharmaceutica Sinica B,2022,第10期 Bo Qin¹，Gregory B.Craven²，Pengjiao Hou¹，Julian Chesti³，Xinran Lu³，Emma S.Child²，Rhodri M.L.Morgan²，Wenchao Niu⁴，Lina Zhao⁴，Alan Armstrong³，David J.Mann²，Sheng Cui¹（NHC Key Laboratory of Systems Biology of Pathogens，Institute of Pathogen Biology，Chinese Academy of Medical Sciences & Peking Union Medical College；Department of Life Sciences，Imperial College London，South Kensington Campus；Department of Chemistry，Imperial College London，Molecular Sciences Research Hub，White City Campus；CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety，Institute of High Energy Physics，University of Chinese Academy of Sciences）.Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease[J].Acta Pharmaceutica Sinica B,2022,第10期 Xuan Yang¹，Yalong Wang¹，Junke Zhao¹，Hehui Rong¹，Yujun Chen²，Mengting Xiong¹，Xiaoxing Ye¹，Shihui Yu^1,3，Haiyan Hu^1,3（School of Pharmaceutical Sciences，Sun Yat-sen University；The First Affiliated Hospital of Guangxi Medical University；Guangdong Provincial Key Laboratory of Chiral Molecules and Drug Discovery，Sun Yat-sen University）.Coordinated regulation of BACH1 and mitochondrial metabolism through tumor-targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy[J].Acta Pharmaceutica Sinica B,2022,第10期 Xianzi Zheng，Zhezheng Fang，Weizi Huang，Jianping Qi，Xiaochun Dong，Weili Zhao，Wei Wu，Yi Lu（Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University）.Ionic co-aggregates （ICAs） based oral drug delivery：Solubilization and permeability improvement[J].Acta Pharmaceutica Sinica B,2022,第10期 Yamin Liu^1,2，Qiyue Wang¹，Fangyuan Li^3,4，Daishun Ling^1,3,4（Frontiers Science Center for Transformative Molecules，School of Chemistry and Chemical Engineering，National Center for Translational Medicine，Shanghai Jiao Tong University；Department of Chemistry，Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials，Fudan University；Institute of Pharmaceutics，College of Pharmaceutical Sciences，Zhejiang University；Hangzhou Institute of Innovative Medicine，Zhejiang University）.Nature-inspired supramolecular assemblies for precise biomedical imaging and therapy[J].Acta Pharmaceutica Sinica B,2022,第10期 Wei Jinlian Chen Xin Li Yongyun Li Ruoxi Bao Keting Liao Liang Xie Yuqing Yang Tiannuo Zhu Jin Mao Fei Ni Shuaishuai Jia Renbing Xu Xiaofang Li Jian（School of Pharmacy， East China University of Science and Technology， State Key Laboratory of Bioreactor Engineering；Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism；Frontiers Science Center for Materiobiology and Dynamic Chemistry；Shanghai Key Laboratory of New Drug Design， Shanghai， 200237;Department of Ophthalmology， Ninth Peoples Hospital， Shanghai Jiao Tong University School of Medicine， Shanghai， 200025;Cancer Institute， Longhua Hospital， Shanghai University of Traditional Chinese Medicine， Shanghai， 200032;College of Pharmacy， Dali University， Yunnan Key Labo， Dali， 671000;Shanghai Tenth Peoples Hospital， Tongji University School of Medicine， Shanghai， 200092;College of Pharmacy， Hainan University， Haikou， 570228）.Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78eFOXM1eKIF20A pathway[J].Acta Pharmaceutica Sinica B,2022,第10期 Zhicheng Xie^1,2，Lin Li^1,2，Yihao Guo³，Mi Zhang¹，Taiwen Chen^1,2，Yongpeng Li³，Xin Li^1,2，Xi Zhu^1,2，Yu Zhang^1,2，Liguang Lou^1,2,3，Youhong Hu^1,2,3,4（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，UCAS）.Discovery of novel heteroaryl alkynes for highly potent KIT^D816V cells inhibition to treat gastrointestinal stromal tumors[J].Acta Pharmaceutica Sinica B,2022,第10期 Jie Tong²，Dongjie Li^2,3，Hongbo Meng，Diyang Sun⁵，Xiuting Lan²，Min Ni²，Jiawei Ma²，Feiyan Zeng^2,6，Sijia Sun²，Jiangtao Fu⁵，Guoqiang Li^5,7，Qingxin Ji²，Guoyan Zhang²，Qirui Shen⁸，Yuanyuan Wang²，Jiahui Zhu²，Yi Zhao²，Xujie Wang²，Yi Liu²，Shenxi Ouyang²，Chunquan Sheng⁹，Fuming Shen²，Pei Wang⁵（Department of Pharmacy，Shanghai Tenth People’s Hospital，Tongji University School of Medicine；Department of Pharmacy，Shanghai Tenth People's Hospital，Tongji University School of Medicine；Institute of Nuclear Medicine，Tongji University School of Medicine；Department of General Surgery，Shanghai Tenth People’s Hospital，Tongji University School of Medicine；Department of Pharmacology，School of Pharmacy，Naval Medical University/Second Military Medical University；Department of Pharmacy，Shanghai Fourth People's Hospital，Tongji University School of Medicine；Shanghai Key Laboratory of Regulatory Biology，Institute of Biomedical Sciences and School of Life Sciences，East China Normal University；Chemical Biology Research Center，School of Pharmaceutical Sciences，Wenzhou Medical University；Department of Medicinal Chemistry，School of Pharmacy，Naval Medical University/Second Military Medical University）.Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease[J].Acta Pharmaceutica Sinica B,2022,第9期 Feixia Wang¹，Zhanghao Li¹，Li Chen¹，Ting Yang¹，Baoyu Liang¹，Zili Zhang¹，Jiangjuan Shao¹，Xuefen Xu¹，Guoping Yin²，Shijun Wang³，Hai Ding⁴，Feng Zhang¹，Shizhong Zheng¹（Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica，School of Pharmacy，Nanjing University of Chinese Medicine；Department of Anesthesiology，Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine；College of Traditional Chinese Medicine，Shandong University of Traditional Chinese Medicine；Department of General Surgery，Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine）.Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis[J].Acta Pharmaceutica Sinica B,2022,第9期 Longshan Ji¹，Qian Li¹，Yong He²，Xin Zhang¹，Zhenhua Zhou³，Yating Gao¹，Miao Fang¹，Zhuo Yu³，Robim M.Rodrigues⁴，Yueqiu Gao¹，Man Li¹（Laboratory of Cellular Immunity，Institute of Clinical Immunology，Shanghai Key Laboratory of Traditional Chinese Medicine，Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine，Key Laboratory of Liver and Kidney Diseases (Shanghai University of Traditional Chinese Medicine)，Ministry of Education；Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Department of Hepatopathy，Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine；Department of in Vitro Toxicology and Dermato-Cosmetology，Faculty of Medicine and Pharmacy，Vrije Universiteit Brussel）.Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD：A promising drug Potentilla discolor Bunge[J].Acta Pharmaceutica Sinica B,2022,第9期 Xuan Wang，Peng Hua，Chengwei He，Meiwan Chen（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau）.Non-apoptotic cell death-based cancer therapy：Molecular mechanism,pharmacological modulators,and nanomedicine[J].Acta Pharmaceutica Sinica B,2022,第9期 Hongyu Wu¹，Hong Yao¹，Chen He¹，Yilin Jia¹，Zheying Zhu²，Shengtao Xu¹，Dahong Li³，Jinyi Xu¹（State Key Laboratory of Natural Medicines，Department of Medicinal Chemistry，China Pharmaceutical University；Division of Molecular Therapeutics & Formulation，School of Pharmacy，the University of Nottingham；Key Laboratory of Structure-Based Drug Design & Discovery，Ministry of Education，School of Traditional Chinese Materia Medica，Shenyang Pharmaceutical University）.Molecular glues modulate protein functions by inducing protein aggregation：A promising therapeutic strategy of small molecules for disease treatment[J].Acta Pharmaceutica Sinica B,2022,第9期 Rui Cui^1,2，Luo Wang¹，Dongyun Zhang¹，Kun Zhang^3,4，Jianping Dou¹，Linan Dong¹，Yixuan Zhang¹，Jiapeng Wu¹，Longfei Tan⁵，Jie Yu¹，Ping Liang¹（Department of Interventional Ultrasound，PLA General Hospital；Department of Medical Ultrasonics，the Sixth Affiliated Hospital，Sun Yat-sen University；Laboratory of Controllable Preparation and App Department of Medical Ultrasound，Shanghai Tenth People's Hospital，Tongji University School of Medicine；Ultrasound Research and Education Institute，Tongji University School of Medicine；Laboratory of Controllable Preparation and Application of Nanomaterials，Key Laboratory of Cryogenics，Technical Institute of Physics and Chemistry，Chinese Academy of Sciences）.Combination therapy using microwave ablation and D-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression[J].Acta Pharmaceutica Sinica B,2022,第9期首页上一页 1 2 3 4 5 下一页尾页共有11页，转到页

期刊文章列表